Extra Strength Cold-Hot Medicated Patches

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with various conditions, including arthritis, simple backache, bursitis, tendonitis, muscle strains, muscle sprains, bruises, and cramps.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should follow these instructions for patch application. The backing of the patch must be carefully removed, and the sticky side should be applied directly to the affected area. Each patch may be worn for a maximum of 8 hours. If necessary, the application may be repeated, but it should not exceed 4 patches in a 24-hour period. After opening, the pouch should be resealed to maintain the integrity of the remaining patches. Each patch is for single use only and must be discarded after removal.

For children under 12 years of age, it is essential to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Tight bandaging or the application of a heating pad is not recommended, as this may exacerbate adverse effects. Contact with the eyes and mucous membranes should be strictly avoided to prevent irritation or injury. Additionally, application to wounds or damaged skin is contraindicated due to the potential for increased sensitivity and adverse reactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to seek emergency medical assistance immediately if the product is ingested. In such cases, contacting a Poison Control Center is strongly recommended.

Patients should be instructed to discontinue use and consult their healthcare provider under the following circumstances: if the condition worsens, if any redness appears, if irritation develops, or if symptoms persist for more than seven days. Additionally, if symptoms resolve and then recur within a few days, patients should also stop using the product and seek medical advice.

Side Effects

For external use only. Patients should discontinue use and consult a doctor if the condition worsens, if redness is present, if irritation develops, or if symptoms persist for more than 7 days or clear up and then occur again within a few days.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Cold-Hot Medicated Patches (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should be evaluated by a physician prior to use. It is essential to consider the specific needs and potential risks associated with this age group when determining treatment options.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and breastfeeding.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular monitoring of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and contact dermatitis. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should monitor their condition closely and report to their healthcare provider if any of the following occur: worsening of their condition, the presence of redness, the development of irritation, or if symptoms persist for more than 7 days or resolve only to recur within a few days.

Patients should be instructed to use the product strictly as directed. They should be cautioned against bandaging the area tightly or using the product in conjunction with a heating pad. Additionally, patients must be made aware to avoid contact with their eyes and mucous membranes, and they should not apply the product to wounds or damaged skin.

Storage and Handling

The product is supplied in resealable pouches. After opening, it is essential to reseal the pouch to maintain product integrity. Each patch is intended for single use only and should be discarded after use to ensure safety and effectiveness. Proper handling of the product is crucial to prevent contamination and preserve its quality.

Additional Clinical Information

Patients should be informed that the product is administered topically. For adults and children aged 12 years and older, the patch should be applied to the affected area by carefully removing the backing and placing the sticky side against the skin. Each patch can be worn for up to 8 hours and may be repeated as necessary, not exceeding four applications in a 24-hour period. After use, the patch should be discarded, and the pouch resealed. For children under 12 years of age, consultation with a physician is recommended.

Clinicians should counsel patients on the proper use of the product, emphasizing that it should be used only as directed. Patients should avoid bandaging tightly or using heating pads in conjunction with the patch, and contact with eyes and mucous membranes should be avoided. The patch should not be applied to wounds or damaged skin. Patients are advised to discontinue use and consult a doctor if the condition worsens, if redness or irritation occurs, or if symptoms persist for more than 7 days or recur shortly after resolution. Pregnant or breastfeeding patients should seek advice from a healthcare professional before use.

Drug Information (PDF)

This file contains official product information for Extra Strength Cold-Hot Medicated Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)